Radiotracer Innovations in Breast Cancer Imaging: A Review of Recent Progress.
18F-fluorodeoxyglucose
breast cancer
molecular imaging
nuclear medicine
positron emission tomography
radiopharmaceuticals
radiotracers
tumor detection
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
03 Sep 2024
03 Sep 2024
Historique:
received:
31
07
2024
revised:
19
08
2024
accepted:
23
08
2024
medline:
14
9
2024
pubmed:
14
9
2024
entrez:
14
9
2024
Statut:
epublish
Résumé
This review focuses on the pivotal role of radiotracers in breast cancer imaging, emphasizing their importance in accurate detection, staging, and treatment monitoring. Radiotracers, labeled with radioactive isotopes, are integral to various nuclear imaging techniques, including positron emission tomography (PET) and positron emission mammography (PEM). The most widely used radiotracer in breast cancer imaging is
Identifiants
pubmed: 39272726
pii: diagnostics14171943
doi: 10.3390/diagnostics14171943
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng